State-Level Cannabis Tax Revenue Hits $5B Milestone
By Sheeba M. | May 14, 2026 State-Level Cannabis Tax Revenue Hits $5B Milestone TL;DR: Tax windfalls are stabilizing state budgets and reducing pressure on illicit markets—bullish for regulated operators. Combined state cannabis tax revenue exceeded $5 billion in 2025, validating the regulated market model and encouraging additional states to legalize. This milestone signals maturity […]
Cannabis M&A Activity Picks Up in Q2 2026
By Sheeba M. | May 14, 2026 Cannabis M&A Activity Picks Up in Q2 2026 TL;DR: Consolidation signals growing institutional interest in regulated markets, with multi-state operators positioning for federal reform timing. The second quarter of 2026 marks a turning point for cannabis industry consolidation. After a slower 2024-2025, mergers and acquisition activity is accelerating […]
CBD Supply Chain Consolidation – Who Wins When the Commodity Bottleneck Breaks
By Sheeba M. | May 14, 2026 CBD Supply Chain Consolidation – Who Wins When the Commodity Bottleneck Breaks TL;DR: Five years of oversupply has starved CBD infrastructure companies of growth capital, but Colorado’s new hemp licensing regime is reshaping the supply chain—creating acquisition targets for CPG giants and licensing opportunities for established cultivators. The […]
Green Thumb Industries Positions as the Dividend Play in Cannabis
By Sheeba M. | May 14, 2026 Green Thumb Industries Positions as the Dividend Play in Cannabis TL;DR: GTI’s strategic shift toward EBITDA margins and shareholder returns is attracting institutional capital away from high-growth competitors—signaling market maturation and a potential dividend catalyst by Q4 2026. While most cannabis operators are locked in a growth-at-all-costs mentality, […]
Cannabis Earnings Season: What to Watch This Quarter
By Sheeba M. | May 14, 2026 Cannabis Earnings Season: What to Watch This Quarter TL;DR: Q2 earnings from cannabis MSOs will show whether price compression and regulatory pressure can be offset by volume growth—key metric is adjusted EBITDA margin trajectory. Cannabis earnings season is upon us, and investors should focus on three key metrics: […]
Cannabis M&A Activity Signals Market Consolidation
By Sheeba M. | May 14, 2026 Cannabis M&A Activity Signals Market Consolidation TL;DR: Increased M&A activity in cannabis signals consolidation phase as market matures, driving valuations upward for acquisition targets and strategic buyers positioning for federal legalization. The cannabis sector is entering a consolidation phase as larger operators absorb smaller cultivation and retail players. […]
From the Village Green – May 14, 2026
Daily curated intelligence from social media: 280E tax relief, Q1 earnings, June deadlines, and cannabis rescheduling updates.
Curaleaf’s Acquisition Machine: Why $60M in Q2 Deals Signals Confidence in Exit Valuations
By Sheeba M. | May 13, 2026 Curaleaf’s Acquisition Machine: Why $60M in Q2 Deals Signals Confidence in Exit Valuations TL;DR: Curaleaf’s recent acquisition spree ($60M in three deals this quarter) suggests institutional buyers now see $2.50-3.00 per-share valuations achievable by EOY. Strategic consolidation is the new growth vector. Curaleaf just closed three acquisitions in […]
Cannabis Tax Reform Could Unlock $1.5B in MSO Savings — Here’s Who Wins
By Sheeba M. | May 13, 2026 Cannabis Tax Reform Could Unlock $1.5B in MSO Savings — Here’s Who Wins TL;DR: Removal of IRS Section 280E could add $0.15-0.25 per share to mid-cap MSO valuations, with CURLF and CRLBF as the primary beneficiaries. Tax relief alone could represent a $1.5B valuation boost across the sector. […]
Canada’s Cannabis Tax Cut to Fuel MSO Margin Expansion
By Sheeba M. | May 13, 2026 Canada’s Cannabis Tax Cut to Fuel MSO Margin Expansion TL;DR: Canada announced a 50% reduction in federal cannabis excise tax effective June 1, 2026. U.S. MSOs with Canadian operations expect 3-5% margin uplift by Q3. Canada’s federal government announced a landmark 50% reduction in the cannabis excise tax, […]